FDG PET/CT in a patient with spontaneous remission of methotrexate-associated lymphoproliferative disorders after interruption of methotrexate.

We report a case that fluorodeoxyglucose positron emission tomography (FDG PET)/computed tomography (CT) depicted systemically multiple lesions of methotrexate (MTX)-associated lymphoproliferative disorders. A 70-year-old man receiving MTX for rheumatoid arthritis complained of neck swelling. FDG PET/CT revealed multiple FDG-avid lesions in lymph nodes, lungs, bones, and muscles. Lesions in bones and muscles were not detected on X-CT. Final diagnosis of cervical node was confirmed as MTX-associated lymphoproliferative disorders. FDG PET/CT performed 148 days after discontinuing MTX demonstrated complete remission.

[1]  Sheng-Tsung Chang,et al.  EBV-associated diffuse large B-cell lymphoma in a psoriatic treated with methotrexate. , 2009, Pathology, research and practice.

[2]  M. Roarke,et al.  Methotrexate-induced and Epstein-Barr virus-associated B-cell lymphoma of the spine: MR and PET/CT imaging. , 2008, Clinical nuclear medicine.

[3]  Y. Tamaki,et al.  Methtrexate-associated lymphoproliferative disorders. A clinicopathological study of 13 Japanese cases. , 2006, Pathology, research and practice.

[4]  G. Mackie,et al.  Methotrexate-induced pulmonary non-Hodgkin lymphoma. , 2006, Clinical nuclear medicine.

[5]  J. Callen,et al.  Self-resolution of Epstein-Barr virus-associated B-cell lymphoma in a patient with dermatomyositis following withdrawal of mycophenolate mofetil and methotrexate. , 2004, Journal of the American Academy of Dermatology.

[6]  S. Schwartzman,et al.  Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment. , 1997, Seminars in arthritis and rheumatism.

[7]  R. Viraben,et al.  Reversible cutaneous lymphoma occurring during methotrexate therapy , 1996, The British journal of dermatology.

[8]  J. Lacy,et al.  Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  R. Warnke,et al.  Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. , 1994, Human pathology.